Presentation is loading. Please wait.

Presentation is loading. Please wait.

Program: Opening remarks: Thomas Farrington, PHEN President & Founder

Published byΣτυλιανός Πυλαρινός Modified over 6 years ago

Similar presentations

Presentation on theme: "Program: Opening remarks: Thomas Farrington, PHEN President & Founder"— Presentation transcript:

1 Program: Opening remarks: Thomas Farrington, PHEN President & Founder
Featured Speaker: Sharon Bober, Ph.D. Androgen Deprivation Treatment: Jacques Carter, M.D.

2

3 Partners Dr. Ed Benz- President
Ms. Anne Levine- Vice President of External Affairs Ms. Magnolia Contreras- Director Community Benefits Ms. Athene Wilson Glover- Community Benefits Mr. Mark Kennedy- Community Benefits

4 PHEN Rally Against Prostate Cancer Sponsors
Dana Farber Cancer Centocor Ortho Institute Biotech Inc. Roswell Park Cancer Accuracy Institute CyberKnife Dendreon Medivation Ferring Pharmaceuticals Takeda Millenium Genentech BN Immuno Therapeutics US HIFU State Street Bank of America/Merrill Lynch : Perpetual Trust for Charitable Giving

5 April Program April 13th Towards Personalized Medicine for Prostate Cancer Guest Speaker: Dr. Levi Garraway Treatment Options Dr. Jacques Carter

Download ppt "Program: Opening remarks: Thomas Farrington, PHEN President & Founder"

Similar presentations

Napa Valley Oncology Nursing Society From CHIP to Successful Chapter 2010-2012 Karen Stilwell MSN RN CNS OCN November 19, 2012.

Napa Valley Oncology Nursing Society From CHIP to Successful Chapter Karen Stilwell MSN RN CNS OCN November 19, 2012.
Remarks: Thomas A. Farrington, PHEN President and Founder Guest Speaker: Arthur L. Burnett, II, M.D., MBA Professor of Urology Director, Sexual Medicine.

Remarks: Thomas A. Farrington, PHEN President and Founder Guest Speaker: Arthur L. Burnett, II, M.D., MBA Professor of Urology Director, Sexual Medicine.
Program: 2011 PHEN Summit: An Overview. Partners Dr. Ed Benz- President Ms. Anne Levine- Vice President of External Affairs Ms. Magnolia Contreras-

Program: 2011 PHEN Summit: An Overview. Partners Dr. Ed Benz- President Ms. Anne Levine- Vice President of External Affairs Ms. Magnolia Contreras-
CI-1 Update on the Safety of Erythropoietin Products in Patients With Cancer May 4, 2004 Robert DeLap, MD, PhD Vice President, Global Regulatory Affairs.

CI-1 Update on the Safety of Erythropoietin Products in Patients With Cancer May 4, 2004 Robert DeLap, MD, PhD Vice President, Global Regulatory Affairs.
Program: Opening remarks: Thomas Farrington, PHEN President & Founder Featured Speakers: PHEN Survivor Network Action Panel.

Program: Opening remarks: Thomas Farrington, PHEN President & Founder Featured Speakers: PHEN Survivor Network Action Panel.
January 11 th, 2012: Opening Remarks: Thomas Farrington, PHEN President & Founder & Jacques Carter, MD, Dana Farber Cancer Institute Featured Speaker:

January 11 th, 2012: Opening Remarks: Thomas Farrington, PHEN President & Founder & Jacques Carter, MD, Dana Farber Cancer Institute Featured Speaker:
2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Welcome Please Check in for continuing.

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Welcome Please Check in for continuing.
1 COMBIDEX ® (ferumoxtran-10). Introduction, Combidex, Indication Mark Roessel Vice President Regulatory Affairs, Advanced Magnetics, Inc.

1 COMBIDEX ® (ferumoxtran-10). Introduction, Combidex, Indication Mark Roessel Vice President Regulatory Affairs, Advanced Magnetics, Inc.
Speaker: Thomas A. Farrington, President and Founder, PHEN Remarks: Mark Kennedy, MBA, Senior Consultant, PHEN Why Knowledge is the Best Defense Against.

Speaker: Thomas A. Farrington, President and Founder, PHEN Remarks: Mark Kennedy, MBA, Senior Consultant, PHEN Why Knowledge is the Best Defense Against.
MISCELLANEOUS Cost of Program Meetings Guests: $40.00 Retired & Life Retired: $30.00 Prospective Members: Free Please return your reservation card or reply.

MISCELLANEOUS Cost of Program Meetings Guests: $40.00 Retired & Life Retired: $30.00 Prospective Members: Free Please return your reservation card or reply.
PHEN Church Partnerships “Joining Hands in Prayer and Action to Save Lives” Annual “Father’s Day Rally Against Prostate Cancer” The Rally takes place.

PHEN Church Partnerships “Joining Hands in Prayer and Action to Save Lives” Annual “Father’s Day Rally Against Prostate Cancer” The Rally takes place.
Guest Speaker: Richard JaeBong (Rick) Lee, MD, PhD Assistant Physician, Department of Medicine Massachusetts General Hospital Remarks: Mr. Mark Kennedy,

Guest Speaker: Richard JaeBong (Rick) Lee, MD, PhD Assistant Physician, Department of Medicine Massachusetts General Hospital Remarks: Mr. Mark Kennedy,
CI-1 Tarceva ® (erlotinib) Tablets in Combination with Gemcitabine as a 1st-line Treatment of Pancreatic Cancer Presentation to the Oncologic Drugs Advisory.

CI-1 Tarceva ® (erlotinib) Tablets in Combination with Gemcitabine as a 1st-line Treatment of Pancreatic Cancer Presentation to the Oncologic Drugs Advisory.
Speakers: Mr. Mark W. Kennedy, MBA PHEN Director of Outreach Kimberly R. Rogers, Ph.D. PHEN Director of Education Programs PHEN’s Education and Community.

Speakers: Mr. Mark W. Kennedy, MBA PHEN Director of Outreach Kimberly R. Rogers, Ph.D. PHEN Director of Education Programs PHEN’s Education and Community.
A 1 Closing Remarks C. Elaine Jones, Ph.D Vice President Respiratory Regulatory Affairs.

A 1 Closing Remarks C. Elaine Jones, Ph.D Vice President Respiratory Regulatory Affairs.
Dana-Farber Cancer Institute (DFCI) and Prostate Health Education Network (PHEN) Partnership to Eliminate Prostate Cancer Disparities Edward J. Benz, Jr.,

Dana-Farber Cancer Institute (DFCI) and Prostate Health Education Network (PHEN) Partnership to Eliminate Prostate Cancer Disparities Edward J. Benz, Jr.,
“The Impact of Diet and Nutrition on Prostate Cancer” Remarks: Thomas A. Farrington, PHEN President and Founder Guest Speaker: Hillary M. Wright, MEd,

“The Impact of Diet and Nutrition on Prostate Cancer” Remarks: Thomas A. Farrington, PHEN President and Founder Guest Speaker: Hillary M. Wright, MEd,
Speakers: Thomas A. Farrington President and Founder, PHEN J. Jacques Carter, M.D., MPH Associate Professor Harvard Medical School Mark W. Kennedy, MBA.

Speakers: Thomas A. Farrington President and Founder, PHEN J. Jacques Carter, M.D., MPH Associate Professor Harvard Medical School Mark W. Kennedy, MBA.
February 8th, 2012: Opening Remarks: Thomas Farrington, PHEN President & Founder Featured Speaker: Paul L. Nguyen, MD, Dana Farber Cancer Institute Clinical.

February 8th, 2012: Opening Remarks: Thomas Farrington, PHEN President & Founder Featured Speaker: Paul L. Nguyen, MD, Dana Farber Cancer Institute Clinical.
CI-1 Lenalidomide Myelodysplastic Syndromes (Revlimid ®, CC-5013, CDC-501) Graham Burton, MD Senior Vice President Regulatory Affairs Celgene Corporation.

CI-1 Lenalidomide Myelodysplastic Syndromes (Revlimid ®, CC-5013, CDC-501) Graham Burton, MD Senior Vice President Regulatory Affairs Celgene Corporation.

Similar presentations

Ads by Google